MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

  • High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

  • High dose off-label Safinamide treatment in Young Onset Parkinson’s Disease patients

    C. Carrarini, M. Russo, F. Barbone, F. Dono, M. Rispoli, M. Onofrj, A. Thomas (Chieti, Italy)

  • High intensity interval training elevates circulating BDNF and miRNAs level in patients with idiopathic Parkinson’s disease

    P. Malczynska, B. Kaminski, M. Siemiatycka, A. Pawłowska, I. Przybylska, J. Langfort, J. Marusiak, M. Chalimoniuk (Warsaw, Poland)

  • High rate of mutations in complex dystonia revealed by exome sequencing

    T. Wirth, C. Tranchant, N. Drouot, B. Keren, L. Cif, C. Mignot, R. Lefaucheur, L. Lion-François, A. Méneret, D. Gras, E. Flamand-Roze, C. Laroche, P. Burbaud, S. Bannier, O. Boukbiza, MA. Spitz, V. Laugel, M. Bereau, D. Doummar, G. Rudolf, M. Anheim, J. Chelly (Illkirch-Graffenstaden, France)

  • High repressive activity of olive extracts on the cell line model of Parkinson disease against ROS induction

    D. Morshedi (Tehran, Islamic Republic of Iran)

  • High-Beta and High-Gamma Power Oscillations from Subthalamic Nucleus distinguishes Parkinson’s Disease Subtypes

    F. Godinho, J. Luccas, B. Bianqueti, A. Fim Neto, T. Almeida, MS. Rocha, T. Yoneyama, D. Soriano (São Bernardo, Brazil)

  • High-throughput screening using a Drosophila model of Parkinson’s disease

    FJ. Lopez, C. Solana, E. Masia, MJ. Vicent, N. Paricio (Valencia, Spain)

  • Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

    S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

  • Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

    A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley